| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 8 |
| 1 | TOBRAMYCIN AND DEXAMETHASONE | 7 |
| 2 | LEVOFLOXACIN | 5 |
| 3 | LEVOFLOXACIN IN 5% DEXTROSE | 5 |
| 4 | TOBRAMYCIN | 5 |
| 5 | BRINZOLAMIDE | 4 |
| 6 | PREDNISOLONE ACETATE | 4 |
| 7 | CYCLOSPORINE | 3 |
| 8 | DENOSUMAB | 3 |
| 9 | DICLOFENAC | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | 1 | 0.1000 |
| 1 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 2 | SODIUM HYALURONATE | 2 | 0.0024 |
| 3 | TOBRAMYCIN AND DEXAMETHASONE | 7 | 0.0021 |
| 4 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 5 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 2 | 0.0018 |
| 6 | HYALURONATE SODIUM | 2 | 0.0013 |
| 7 | TROPICAMIDE | 2 | 0.0012 |
| 8 | GATIFLOXACIN | 2 | 0.0011 |
| 9 | BALANCED SALT SOLUTION | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 3 | 0.0003 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 5 | 0.0002 |
| 2 | Aminoglycoside Antibacterial [EPC] | 10 | 0.0002 |
| 3 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 3 | 0.0002 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Anticholinergic [EPC] | 2 | 0.0001 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 7 | 0.0001 |
| 9 | Prostaglandin Analog [EPC] | 5 | 0.0001 |